Shuguang Fang
Wecare Probiotic Research and Development Center (WPC) Wecare Probiotics Co., Ltd Suzhou China
- Papers in database
- 4
- Primary author
- 1 paper
- Years active
- 2025 – 2026
- Health outcomes studied
- 1
Health Outcomes Studied
Papers (4)
- 2026Primary authorClinical Safety and Tolerability of <i>Bifidobacterium bifidum</i> BBi32: An 8-Week Randomized, Double-Blind, Placebo-Controlled Trial With Genomic and In Vitro Corroboration.10.1002/fsn3.71420
- 2026Gut microbiota and immune regulation by Lactobacillus delbrueckii subsp. bulgaricus LB42: From preclinical safety assessment to clinical evidence.10.1016/j.fct.2025.115851
- 2026Multi-Strain Probiotics BLa80, LRa05, and BBr60 Modulate Inflammation, Bile Acids, and Gut Microbiota in Type 2 Diabetes: A Randomized Controlled Trial.10.1002/fsn3.71735
- 2025Efficacy and Safety of <i>Lactobacillus acidophilus</i> LA85 in Preventing Antibiotic-Associated Diarrhea: A Randomized, Placebo-Controlled Study.10.1002/fsn3.70490